Acadian Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.5M | Buy |
2,662,524
+64,230
| +2% | +$519K | 0.04% | 299 |
|
|
2025
Q1 | $21.8M | Buy |
2,598,294
+880,471
| +51% | +$7.37M | 0.06% | 217 |
|
|
2024
Q4 | $13.6M | Buy |
1,717,823
+546,736
| +47% | +$4.33M | 0.04% | 299 |
|
|
2024
Q3 | $9.74M | Buy |
1,171,087
+359,234
| +44% | +$2.99M | 0.03% | 351 |
|
|
2024
Q2 | $5.15M | Buy |
811,853
+710,598
| +702% | +$4.51M | 0.02% | 486 |
|
|
2024
Q1 | $613K | Buy |
101,255
+11,415
| +13% | +$69.1K | ﹤0.01% | 963 |
|
|
2023
Q4 | $545K | Buy |
+89,840
| New | +$545K | ﹤0.01% | 1011 |
|
|
2022
Q4 | – | Sell |
-7,618
| Closed | -$15K | – | 1763 |
|
|
2022
Q3 | $15K | Hold |
7,618
| – | – | ﹤0.01% | 1617 |
|
|
2022
Q2 | $24K | Sell |
7,618
-52,418
| -87% | -$165K | ﹤0.01% | 1594 |
|
|
2022
Q1 | $248K | Sell |
60,036
-56,410
| -48% | -$233K | ﹤0.01% | 1162 |
|
|
2021
Q4 | $556K | Buy |
116,446
+26,507
| +29% | +$127K | ﹤0.01% | 987 |
|
|
2021
Q3 | $478K | Sell |
89,939
-82,621
| -48% | -$439K | ﹤0.01% | 1059 |
|
|
2021
Q2 | $883K | Buy |
172,560
+93,177
| +117% | +$477K | ﹤0.01% | 960 |
|
|
2021
Q1 | $534K | Buy |
+79,383
| New | +$534K | ﹤0.01% | 1168 |
|
|
2020
Q4 | – | Sell |
-10,914
| Closed | -$42K | – | 2188 |
|
|
2020
Q3 | $42K | Hold |
10,914
| – | – | ﹤0.01% | 1900 |
|
|
2020
Q2 | $52K | Sell |
10,914
-34,086
| -76% | -$162K | ﹤0.01% | 1904 |
|
|
2020
Q1 | $157K | Hold |
45,000
| – | – | ﹤0.01% | 1253 |
|
|
2019
Q4 | $217K | Hold |
45,000
| – | – | ﹤0.01% | 1272 |
|
|
2019
Q3 | $131K | Hold |
45,000
| – | – | ﹤0.01% | 1418 |
|
|
2019
Q2 | $323K | Buy |
45,000
+22,073
| +96% | +$158K | ﹤0.01% | 1119 |
|
|
2019
Q1 | $325K | Buy |
+22,927
| New | +$325K | ﹤0.01% | 1227 |
|